This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
APO-SAXAGLIPTIN
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-SAXAGLIPTIN in Canada?
Yes. APO-SAXAGLIPTIN 2.5MG has an active shortage reported to Health Canada (last updated July 9, 2026).
Why is APO-SAXAGLIPTIN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-SAXAGLIPTIN be available again?
The estimated resolution date (July 10, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02507471
Strength
2.5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
SAXAGLIPTIN
Tier
Unrated
Last Updated
2026-07-10
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
APO-SAXAGLIPTIN has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178